Bernstein Harold bought MAZE
September 1, 2026 · Form 4 insider transaction
Bernstein Harold bought 16,141 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $168.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,141
Price
$10.42
Total value
$168.2K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after16,141
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.